MBK bids S$360m for pharmaceutical company

Private equity looks to take advantage of the refuge the pharmaceutical sector offers in uncertain economic times.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this